씨엑스아이

900120KOSDAQ기타 금융업

63.0 / 100

Reference Date: 2026-07-24

Financial Score13.0 / 40

News Sentiment20.0 / 25

Momentum15.0 / 20

Disclosure15.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Surged 198.7% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

CXI focuses on the production and sales of health foods in China, capitalizing on the rapidly growing Chinese health food market. While the market shows significant growth potential, challenges such as insufficient R&D investment, over-advertising, and counterfeit products remain notable issues.

Number of Employees

—

Average Salary

—

Score Calculation Basis

Detailed Financial Score

PER

198.70Industry Average 7.940.0Point

25.0x industry avg (risky)

PBR

5.02Industry Average 0.450.0Point

11.2x industry avg (risky)

ROE

2.56Industry Average 5.451.0Point

Well below industry avg

Debt Ratio

0.11Industry Average 16.998.0Point

Half of industry avg (excellent)

Trend 2023~20254.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼10.6% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲60.8% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 3.7% (improving, 3yr)

Detailed News Sentiment

4 totalPositive 4Neutral 0Negative 0Average Sentiment Score 80

Positive
씨엑스아이, 최대주주 300억 자금 투입…유증 이어 장내매수로 책임경....
씨엑스아이 최대주주가 추가 자금을 투입하여 상장 유지 의지를 재확인하고 기업 가치 제고와 주주 신뢰 회복을 추진함.
Positive
씨엑스아이, 최대주주 유증·장내매수 추진…"상장유지 의지"
최대주주 린진성 대표의 유증 및 장내매수 추진으로 회사의 자금 조달 능력 강화와 상장 유지 의지가 확인되어 긍정적 영향 예상.
Positive
씨엑스아이, 66억원 규모 제3자배정 유상증자 결정
씨엑스아이의 유상증자 결정으로 상장 유지 기반 강화 및 사업 투자 재원 확보가 기대되어 긍정적 영향 예상.

Detailed Momentum

52-week position8.0Point

Near 52w high (95%, uptrend)

Current 1,168Won52-week high 1,20952-week low 352

1-month return6.0Point

1m +198.72% (strong rise)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

15 totalPositive 3Neutral 12Negative 0

Neutral[기재정정]주주총회소집결의 (임시주주총회)2026-07-21
Positive주요사항보고서(유상증자결정)2026-07-21
Neutral주식병합결정2026-07-21
Neutral임원ㆍ주요주주특정증권등거래계획보고서2026-07-21
Neutral주식등의대량보유상황보고서(약식)2026-07-16